BANNSIDE PHARMACY LTD

Company Registration Number:
NI056112 (Northern Ireland)

Unaudited abridged accounts for the year ended 31 August 2025

Period of accounts

Start date: 01 September 2024

End date: 31 August 2025

BANNSIDE PHARMACY LTD

Contents of the Financial Statements

for the Period Ended 31 August 2025

Balance sheet
Notes

BANNSIDE PHARMACY LTD

Balance sheet

As at 31 August 2025


Notes
2025
2024


£
£
Fixed assets
Tangible assets: 3 267,231 265,374
Total fixed assets: 267,231 265,374
Current assets
Stocks: 85,700 77,600
Debtors:   87,747 71,599
Cash at bank and in hand: 140,210 174,869
Total current assets: 313,657 324,068
Creditors: amounts falling due within one year:   (211,674) (226,704)
Net current assets (liabilities): 101,983 97,364
Total assets less current liabilities: 369,214 362,738
Total net assets (liabilities): 369,214 362,738
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 369,212 362,736
Shareholders funds: 369,214 362,738

The notes form part of these financial statements

BANNSIDE PHARMACY LTD

Balance sheet statements

For the year ending 31 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 10 December 2025
and signed on behalf of the board by:

Name: MR EOGHAN OBRIEN
Status: Director

The notes form part of these financial statements

BANNSIDE PHARMACY LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BANNSIDE PHARMACY LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

2. Employees

2025 2024
Average number of employees during the period 21 21

BANNSIDE PHARMACY LTD

Notes to the Financial Statements

for the Period Ended 31 August 2025

3. Tangible Assets

Total
Cost £
At 01 September 2024 454,291
Additions 13,581
At 31 August 2025 467,872
Depreciation
At 01 September 2024 188,917
Charge for year 11,724
At 31 August 2025 200,641
Net book value
At 31 August 2025 267,231
At 31 August 2024 265,374